| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |